
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other brea... Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0102 | 1.24390243902 | 0.82 | 0.92 | 0.765 | 647470 | 0.79712914 | CS |
4 | 0.0049 | 0.593723494487 | 0.8253 | 0.9772 | 0.7203 | 719883 | 0.84675102 | CS |
12 | -0.4698 | -36.1384615385 | 1.3 | 1.32 | 0.7203 | 834360 | 0.98680092 | CS |
26 | -0.4398 | -34.6299212598 | 1.27 | 1.66 | 0.7203 | 700964 | 1.18975014 | CS |
52 | -0.1698 | -16.98 | 1 | 2.31 | 0.7203 | 1044799 | 1.40653562 | CS |
156 | -0.5198 | -38.5037037037 | 1.35 | 2.31 | 0.5 | 869498 | 1.16914955 | CS |
260 | -0.5098 | -38.0447761194 | 1.34 | 9.8 | 0.5 | 3581710 | 3.14415087 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions